A recent phase III randomized trial found an investigational oral small-molecule GLP-1 receptor agonist significantly ...

Defenders of Medicaid cuts point to the Oregon Health Insurance Experiment to argue that the cuts won’t harm people’s health.

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 diabetes.

Engaging in more than 150 minutes of physical activity per week quadrupled the odds of reversing prediabetes to normal ...